An error in the NSW Pharmacy Trial for skin conditions guidelines for shingles risks inappropriate patient referral and delayed treatment, say ophthalmologists.
In July, NSW started the NSW Pharmacy Trial for skin conditions , allowing participating pharmacists to prescribe treatment for eczema, shingle, impetigo and mild plaque psoriasis.
The plan attracted the apprehension of the Australian College of Dermatologists, who told The Medical Republic at the time that it was critical that models of care were underpinned by appropriate clinical governance and protocols.
“Some serious and malignant conditions can masquerade as common diseases of the skin,” they said.
“Misdiagnosis can lead to incorrect treatment, dangerous delays to appropriate treatment, and result in patients experiencing significant financial burden due to ineffective treatments.”
This week, the Medical Journal of Australia published a letter to the editor by a group of ophthalmologists outlining an error in the trial’s NSW Pharmacy Trial’s clinical practice guidelines.
